Lord, Abbett & Co. LLC Charles River Laboratories International, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $31.4 Billion
  • Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 108,715 shares of CRL stock, worth $20.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
108,715
Previous 108,715 -0.0%
Holding current value
$20.6 Million
Previous $21.4 Million -0.0%
% of portfolio
0.07%
Previous 0.07%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$187.96 - $245.29 $1.12 Million - $1.46 Million
5,959 Added 5.8%
108,715 $21.4 Million
Q2 2024

Oct 07, 2024
BUY
$206.39 - $268.73 $176,050 - $229,226
853 Added 0.84%
102,756 $21.2 Million
Q2 2024

Aug 14, 2024
BUY
$206.39 - $268.73 $176,050 - $229,226
853 Added 0.84%
102,756 $21.2 Million
Q1 2024

Oct 07, 2024
SELL
$203.52 - $273.43 $24,829 - $33,358
-122 Reduced 0.12%
101,903 $27.6 Million
Q1 2024

May 09, 2024
SELL
$203.52 - $273.43 $24,829 - $33,358
-122 Reduced 0.12%
101,903 $27.6 Million
Q4 2023

Oct 07, 2024
SELL
$164.52 - $238.84 $200,549 - $291,145
-1,219 Reduced 1.18%
102,025 $24.1 Million
Q4 2023

Feb 12, 2024
SELL
$164.52 - $238.84 $200,549 - $291,145
-1,219 Reduced 1.18%
102,025 $24.1 Million
Q3 2023

Oct 07, 2024
BUY
$194.44 - $217.61 $78,942 - $88,349
406 Added 0.39%
103,244 $20.2 Million
Q3 2023

Nov 13, 2023
BUY
$194.44 - $217.61 $78,942 - $88,349
406 Added 0.39%
103,244 $20.2 Million
Q2 2023

Oct 07, 2024
SELL
$183.71 - $210.25 $4.83 Million - $5.53 Million
-26,292 Reduced 20.36%
102,838 $21.6 Million
Q2 2023

Aug 14, 2023
SELL
$183.71 - $210.25 $4.83 Million - $5.53 Million
-26,292 Reduced 20.36%
102,838 $21.6 Million
Q1 2023

Oct 07, 2024
SELL
$191.89 - $259.92 $211,078 - $285,912
-1,100 Reduced 0.84%
129,130 $26.1 Million
Q1 2023

May 12, 2023
SELL
$191.89 - $259.92 $211,078 - $285,912
-1,100 Reduced 0.84%
129,130 $26.1 Million
Q4 2022

Oct 07, 2024
BUY
$197.11 - $250.07 $5.42 Million - $6.87 Million
27,474 Added 26.74%
130,230 $28.4 Million
Q4 2022

Feb 10, 2023
BUY
$197.11 - $250.07 $2.72 Million - $3.45 Million
13,778 Added 11.83%
130,230 $28.4 Million
Q3 2022

Nov 14, 2022
BUY
$182.44 - $250.54 $153,067 - $210,203
839 Added 0.73%
116,452 $22.9 Million
Q2 2022

Aug 12, 2022
BUY
$204.13 - $302.4 $1.85 Million - $2.74 Million
9,072 Added 8.52%
115,613 $24.7 Million
Q1 2022

May 13, 2022
SELL
$255.51 - $362.11 $1.25 Million - $1.77 Million
-4,880 Reduced 4.38%
106,541 $30.3 Million
Q4 2021

Feb 11, 2022
SELL
$351.38 - $448.68 $3.36 Million - $4.29 Million
-9,555 Reduced 7.9%
111,421 $42 Million
Q3 2021

Nov 09, 2021
SELL
$372.64 - $458.3 $10.1 Million - $12.4 Million
-27,107 Reduced 18.31%
120,976 $49.9 Million
Q2 2021

Aug 11, 2021
SELL
$294.17 - $371.65 $9.95 Million - $12.6 Million
-33,816 Reduced 18.59%
148,083 $54.8 Million
Q1 2021

May 11, 2021
SELL
$249.67 - $299.48 $4.35 Million - $5.21 Million
-17,408 Reduced 8.73%
181,899 $52.7 Million
Q4 2020

Feb 09, 2021
SELL
$222.0 - $252.62 $6.17 Million - $7.02 Million
-27,805 Reduced 12.24%
199,307 $49.8 Million
Q3 2020

Nov 12, 2020
SELL
$175.56 - $226.45 $8.65 Million - $11.2 Million
-49,262 Reduced 17.82%
227,112 $51.4 Million
Q2 2020

Aug 14, 2020
SELL
$118.84 - $189.72 $2.91 Million - $4.64 Million
-24,457 Reduced 8.13%
276,374 $48.2 Million
Q1 2020

May 14, 2020
SELL
$98.9 - $178.34 $6.45 Million - $11.6 Million
-65,205 Reduced 17.81%
300,831 $38 Million
Q4 2019

Feb 14, 2020
SELL
$126.05 - $152.76 $9.67 Million - $11.7 Million
-76,677 Reduced 17.32%
366,036 $55.9 Million
Q3 2019

Nov 14, 2019
SELL
$125.07 - $143.67 $6.04 Million - $6.94 Million
-48,313 Reduced 9.84%
442,713 $58.6 Million
Q2 2019

Aug 14, 2019
SELL
$123.4 - $148.55 $23.2 Million - $27.9 Million
-187,971 Reduced 27.68%
491,026 $69.7 Million
Q1 2019

May 15, 2019
SELL
$104.82 - $146.73 $17.8 Million - $24.9 Million
-169,429 Reduced 19.97%
678,997 $98.6 Million
Q4 2018

Feb 14, 2019
SELL
$105.09 - $137.23 $7.32 Million - $9.56 Million
-69,692 Reduced 7.59%
848,426 $96 Million
Q3 2018

Nov 14, 2018
BUY
$112.11 - $134.54 $18 Million - $21.6 Million
160,214 Added 21.14%
918,118 $124 Million
Q2 2018

Aug 14, 2018
BUY
$102.37 - $117.25 $29.1 Million - $33.4 Million
284,749 Added 60.18%
757,904 $85.1 Million
Q1 2018

May 15, 2018
SELL
$98.19 - $115.2 $19.7 Million - $23.1 Million
-200,173 Reduced 29.73%
473,155 $50.5 Million
Q4 2017

Feb 14, 2018
SELL
$100.43 - $118.09 $8.16 Million - $9.6 Million
-81,263 Reduced 10.77%
673,328 $73.7 Million
Q3 2017

Nov 14, 2017
BUY
$96.72 - $109.26 $9.96 Million - $11.2 Million
102,939 Added 15.8%
754,591 $81.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
651,652
651,652 $65.9 Million

Others Institutions Holding CRL

# of Institutions
695
Shares Held
52.2M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.65B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email